Sax Wealth Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Sax Wealth Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-333	Closed	-$3K	–	185
2023 Q1	$3K	Hold	333	–	–	﹤0.01%	177
2022 Q4	$3.91K	Hold	333	–	–	﹤0.01%	170
2022 Q3	$7K	Hold	333	–	–	﹤0.01%	158
2022 Q2	$8K	Hold	333	–	–	﹤0.01%	164
2022 Q1	$17K	Hold	333	–	–	﹤0.01%	174
2021 Q4	$23K	Hold	333	–	–	﹤0.01%	179
2021 Q3	$31K	Hold	333	–	–	0.01%	169
2021 Q2	$34K	Hold	333	–	–	0.01%	159
2021 Q1	$31K	Hold	333	–	–	0.01%	149
2020 Q4	$28K	Buy	+333	New	+$28.4K	0.01%	133

Other funds holding VBIV

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return